INTRODUCTION
Effect of antimalarial drugs on gametocytogenesis. Experimental Parasitology 93, 45-54. The proportion of asexual blood-stage malaria parasites that develop into transmission stages (gametocytes) can inMammalian malaria parasites (Plasmodium spp.) undergo crease in response to stress. We investigated whether stress imposed by cycles of asexual replication in red blood cells, with a small a variety of antimalarial drugs administered before or during infection proportion of the asexual parasites producing nonreplicating increased gametocyte production (gametocytogenesis) in vivo in the transmission stages, gametocytes. In vitro studies have demrodent malaria parasite, Plasmodium chabaudi. All methods of drug treatment greatly reduced the numbers of asexual parasites produced onstrated that gametocyte production (gametocytogenesis) during an infection but resulted in either no reduction in numbers of of the human malaria parasite Plasmodium falciparum is gametocytes or a smaller reduction than that experienced by asexuals. upregulated in response to a variety of stimuli, most of which
We used a simple model to estimate temporal variation in gametocyte create conditions unfavorable for asexual growth (Mons production. Temporal patterns of gametocytogenesis did not greatly 1985; Carter and Graves 1988; Sinden et al. 1996) . If indiffer between untreated and prophylaxis infections, with rates of gametocytogenesis always increasing as the infection progressed. In concreased gametocytogenesis is a general response to unfavortrast, administration of drugs 5 days after infection stimulated increased able conditions, it may be expected following novel stresses, rates of gametocytogenesis early in the infection, resulting in earlier such as antimalarial drugs (Buckling et al. 1997) .
peak gametocyte densities relative to untreated infections. Given the Antimalarial drugs by definition kill malaria parasites. correlation between gametocyte densities and infectivity to mosquito However, if drugs are used in doses which fail to kill all vectors, and the high frequency of subcurative drug therapy and prophylaxis in human populations, these data suggest that antimalarial drugs parasites, at least some survivors may suffer ill effects and may frequently have only a small effect on reducing malaria transmisbe stimulated to produce gametocytes. Indeed, subcurative sion and may help to explain the rapid spread of drug-resistant genotherapy is common (Wernsdorfer 1994) , as is partially protypes. ᭧ 1999 Academic Press tective prophylaxis, as evidenced by the high proportion of Index Descriptors and Abbreviations: Apicomplexan parasite; Plasindividuals with low drug concentrations detected in blood modium chabaudi; malaria; gametocytogenesis; gametocytes; postinfection (pi); antimalarial chemotherapy; antimalarial prophylaxis; quiand urine Hogh et al. 1995) . Because nine, pyrimethamine, chloroquine; red blood cells (rbc); dimethyl of the generally positive correlation between gametocyte sulfoxide (DMSO); standard error of the mean (SEM); analysis of density and infectivity to the mosquito vector (Carter and variance (ANOVA) . Graves 1988; Buckling et al. 1997; Taylor and Read 1997; Taylor et al. 1997) , stress-induced gametocyte production may limit the impact of antimalarial drugs on malaria transmission. Further, if drug-resistant parasites are more likely A number of clinical studies have investigated the effect libitum.
of antimalarial drugs on gametocytogenesis in humans (reChloroquine solution was prepared from a stock of 40 mg/ml chloviewed in Buckling et al. 1997) . These are, however, necesroquine sulphate (Nivaquine) diluted in distilled water. Quinine and sarily ambiguous: for ethical reasons, drug doses must be mefloquine solutions were prepared by dissolving their hydrochlorides in distilled water, except in the cases in which pyrimethamine (base) curative and there can be no untreated controls. Any changes was used in experiments, in which case all drugs were dissolved in in gametocyte densities may therefore represent the natural DMSO. Drug solutions were administered orally using a lubricated progression of the infection. However, a series of controlled catheter in approximately 0.1-ml volumes; doses are shown in Table   experiments on the effect of subcurative therapy with chlo-I. Drug treatment occurred on day 5 pi between 1600 and 1700 h and roquine in the rodent malaria, Plasmodium chabaudi, have prophylaxis approximately 1 h before parasite inoculation (day 0 pi). Control mice were given 0.1 ml distilled water or DMSO, depending on been performed. These showed that drug therapy more than doubled the proportion of circulating parasites that were gametocytes, induced early peak gametocyte densities and, importantly, had no impact on infectivity to mosquitoes [Beale et al. 1978] from the WHO Registry of Standard Malaria Parasites maintained at a Six experiments were carried out, each including a variety of treatments; experiment number thus identifies experimental blocks the University of Edinburgh, UK) in a 0.1-ml intraperitoneal inoculum of 50% Ringer's solution (27 mM KCl, 27 mM CaCl 2 , 0.15 M NaCl), run concurrently. b Each treatment was compared with untreated infections in two to 45% heat-inactivated calf serum, and 5% 200 units/ml heparin solution. Mice, age-matched within experiments, were housed in cages of two three of these experiments, resulting in two to three 'Experimental blocks' replicating the relevant comparisons. to four animals at a temperature of 25 Ϯ 1ЊC with a 0700 to 1900 h light cycle and provided with 41B rat and mouse maintenance diet c mg/kg mouse weight.
the solvent used for the drugs in each experiment. Details of individual case for P. falciparum [Bruce et al. 1990] ), the number of gametocytes on day t ϩ 2 (G tϩ2 )can be written as experiments are shown in Table I .
Thin blood smears from the tail vein were taken approximately every second day from day 4 or 5 pi and Giemsa-stained, and asexual parasites G tϩ2 ϭ sgmA t , (1) were counted per 1.5 ϫ 10 3 rbc. At low asexual densities parasites were counted per 10 4 rbc. Mature gametocytes were counted per where A t refers to the number of asexuals on day t. 1.25 ϫ 10 4 rbc. Parasite densities were calculated from rbc densities, The asexual cycle of P. chabaudi is 24 h (Cox 1988) , so that two measured by flow cytometry (Coulter Electronics) every second day, asexual cycles occur during the maturation time of a gametocyte. multiplied by parasites per rbc.
Assuming that both asexual mortality, s, and the probability of an We used a simple exponential growth model to estimate the proporasexual parasite producing gametocytes, g, are constant during the 2-tion of asexual parasites that produced gametocytes on individual days day period, the number of asexuals on day t ϩ 2 (A tϩ2 ) can be written as (see Fig. 1 ). The synchrony of parasite replication in P. chabaudi infections (Cox 1988 ) simplifies matters. The maturation period of P. (Gautret et al. 1997) , such that a proportion, g, of the asexual parasites at day t will produce gametocytes that will mature on day t ϩ 2. P. falciparum gametocytes
The proportion of parasites that produced gametocytes can be estibecome less vulnerable to immune and drug clearance as they mature, mated from observed densities of asexuals and gametocytes by combinprobably because they express less immunogenic antigens and have ing Eqs. (1) and (2): reduced metabolic activity (Carter and Graves 1988) . Age-dependent mortality of P. chabaudi gametocytes is likely to be similar. It is therefore assumed that survival probability (s) in the first 24 h after asexual densities were measured is the same for gametocytes and g ϭ
(3) asexuals. This period encompasses the time taken for asexual parasites to mature and rupture (schizogony), releasing the gametocyte or asexual progeny. Schizogony occurs around midnight in clones ER and CR under the employed light-dark cycle (McLean 1986) , approximately Some of the simplifying assumptions used to derive this approximation 7 h after parasite densities at time t were measured. Zero gametocyte may not always hold. In particular, it is likely that rates of gametocytomortality is assumed in the second 24-h period.
genesis (g) and survival of parasites (s) will differ between the two The half-life of mature P. chabaudi gametocytes is estimated to be rounds of asexual replication that occur for each estimate of g. Values less than 12 h (A. Buckling, unpubl. data), so that few mature gametoof g were generally very low (see below); differences in g between cytes are likely to contribute to the gametocyte population of the the two periods will thus have only a small effect on the estimates. following day. If we assume that asexual parasites produce m progeny Differences in parasite survival may however be very large, potentially under-estimating or over-estimating g when mortality is greatest during parasites which develop into all gametocytes or asexuals (as is the
FIG. 1. Schematic showing parameters of the model (see text)
. A proportion (g) of asexual parasites measured at time t will produce gametocytes when they reach maturity. Mature parasites undergo schizogony, producing m progeny. A proportion of parasites (s) will survive until t ϩ 1. Surviving asexual parasites then repeat the cycle. Surviving gametocytes undergo no further mortality, reaching maturity at t ϩ 2. the first or second period, respectively. However, by considering the asexual densities on those days were determined to be zero. Rates were additionally calculated for days 14 and 16 pi in prophylaxis extremes of biologically feasible parameter estimates, Crooks et al. (in preparation) demonstrate that the current estimates of gametocytoexperiments, when, unlike the drug-therapy infections, parasite densities were consistently at a detectable level. genesis are a reasonable approximation.
Drug treatment may more strongly affect asexual parasites than Prior to analysis, estimates of total asexuals and total gametocytes were log 10 -transformed, and proportions of gametocytes were squaregametocytes. Pharmacokinetic data, which we summarize under Discussion, make it unlikely that this will cause consistent bias in our root arcsin-transformed, to bring the distributions close to normal. The effect of each method of treatment relative to the appropriate control estimates of g during the bulk of the infection. However, with some caution, we also use Eq. (3) to estimate gametocyte conversion rate infections (i.e., separate analyses were carried out for quinine-therapy, pyrimethamine-therapy, mefloquine-therapy, pyrimethamine prophyimmediately following chemotherapy on day 5 pi, when biologically relevant drug concentrations still occur. The calculation of gametocytolaxis, and chloroquine prophylaxis infections) on each of these measures was determined by ANOVA using GLIM 4, with TREATMENT genesis makes the assumption that gametocytes between 24 and 48 h (when they reach maturity) have zero mortality but that mortality before (drugϩ, drugϪ) and EXPERIMENTAL BLOCK (each method of treatment was compared with untreated infections two to three times; see this is the same as for asexual parasites. These assumptions are probably not greatly violated by drug-imposed mortality. Specific data for P. Table I ) fitted as factors. The interaction term was removed from the statistical model if nonsignificant (P Ͼ 0.05) (Crawley 1993). Analyses chabaudi are not available, although all the drugs used are inactive against mature P. falciparum gametocytes but kill immature forms of days of peak gametocyte density for each infection were carried out as above, except that the data for all drug therapy experiments (Desjardins et al. 1988) . Moreover, mortality during the first 24 h includes the approximately 7 h it takes for asexual parasites to mature.
were pooled together, and likewise for all the prophylaxis data. Daily rates of gametocytogenesis (g, in Eq. 3) were highly overGiven the rapid absorption and subsequent parasite-killing activity of these drugs (at least in people [Desjardins et al. 1988] ), drug-induced dispersed and in no way approximated a normal distribution, regardless of transformation. The data consisted of many zeros and very low mortality is likely to be greatest for these pre-schizont asexual parasites, probably overshadowing any possible differences in mortality of the values, as well as much higher values (Fig. 2) . Even the use of nonparametric ranking procedures is unlikely to provide an appropriate solution gametocyte or asexual progeny produced by the survivors of the drug treatment. The possibility that gametocytes that reached maturity on to this problem, given that variation in the very low values will often represent the presence or absence of a single gametocyte in the surveyed day 6 pi (which might not have been affected by the drug therapy on day 5 pi) would result in a significant overestimation of drug-induced microscopic fields. A nominal classification system was therefore used, with each rate of gametocytogenesis classified as high or low, based gametocytogenesis is also unlikely. The half-life of P. chabaudi gametocytes is less than 12 h (A. Buckling, unpubl. data); thus, very few of on whether the value was less or greater than the median of the data set. The drug therapy and prophylaxis data sets were analyzed the small number of mature gametocytes present on day 6 pi would contribute to the population on day 7 pi.
separately. To control for multiple sampling from the same infection, the median of a data set was calculated as the median of the medians The following summary measures were determined for each infection.
for each infection within the data set. Data for each day was analyzed using 2 tests of independence (with Yates's correction for continuity) (1) Total asexuals. This was estimated as the total number of parasites circulating in the peripheral blood between days 7 and 18 pi for to determine whether the proportion of infections that had high rates of gametocytogenesis (median Ͼ 0.008 and 0.003, for drug therapy drug therapy comparisons and between days 0 and 18 pi for prophylaxis comparisons. Parasite densities prior to day 7 pi were not used for the and prophylaxis comparisons, respectively) differed between all drug therapy and the appropriate untreated infections, and all prophylaxis former because the effects of drug treatment on gametocytogenesis would not be apparent, and by day 18 pi, the vast majority of parasites and the appropriate untreated infections. had been cleared by their hosts. Estimates of total parasites between these days were obtained by integrating under the parasite density through time curves for each infection. This is a reasonably accurate measure of total numbers of asexuals (between the appropriate time periods) given the 24-h asexual cycle of P. chabaudi (Cox 1988) .
(2) Total gametocytes. An index of the total number of gametocytes produced during an infection was estimated between the same time periods as for the asexual parasites by integrating under the gametocyte density through time curves. This measure will be reasonably accurate, as the half-life of gametocytes is less than 12 h and measures were taken every second day. The sum of the gametocyte densities on each day is likely to be well correlated with total transmission probability: gametocyte densities at any point in time correlate with both the proportion of mosquitoes infected and parasite densities within mosquitoes. 
RESULTS
Statistical tests of the main effects of drug therapy and prophylaxis on total asexual parasites and gametocytes produced during an infection and the proportion of total parasites that were gametocytes are summarized in Table II . Subcurative chemotherapy was achieved. Quinine, pyrimethamine, and mefloquine administered on day 5 pi reduced total asexuals by approximately 75% in all cases. However, gametocyte densities were not correspondingly reduced: total number of gametocytes was reduced by about 25% by quinine and was not significantly affected by the other drugs. The proportions of parasites that were gametocytes were approximately four times higher following quinine and pyrimethamine therapy than in untreated infections. There was no significant change in the proportion of gametocytes following mefloquine therapy (Figs. 3 and 4) .
Treatment prior to infection also had a greater impact on asexuals than on gametocyte densities. Following both pyrimethamine and chloroquine prophylaxis, the total number of asexual parasites appearing in an infection was half that in untreated infection but total gametocyte numbers were not significantly lower. The resultant proportion of gametocytes was not significantly different from untreated infections following chloroquine prophylaxis but was almost twice that of untreated infections following pyrimethamine prophylaxis (Figs. 5 and 6 ).
Both clones CR and ER were used in at least one experimental block each for all comparisons between treated and untreated infections. Significant differences between experimental blocks (P Ͻ 0.05) occurred for total gametocytes tions; P Ͻ 0.05) for total asexuals and total gametocytes in * P Ͻ 0.05. ** P Ͻ 0.001.
the pyrimethamine prophylaxis experiments and for total asexuals in the chloroquine prophylaxis experiments, although the treatment effects were always in the same direction within experimental blocks. These effects can be attributed to different drug doses being used in the different experimental blocks. There were no other significant experimental block by treatment interactions (P Ͼ 0.1).
Drug treatment on day 5 pi resulted in peak gametocyte density occurring on average 3 days earlier than in untreated infections (days 11 and 14 pi, respectively; Fig. 3 , F 1.45 ϭ 9.0, P Ͻ 0.01). Treatment prior to infection did not induce a change in the timing of peak gametocyte densities (peaks in untreated and prophylaxis infections occurring on average between days 13 and 14 pi; Fig. 5 , F 1.36 ϭ 0.06, P Ͼ 0.1). There were no significant experimental block or interaction effects (P Ͼ 0.1 in all cases).
Statistical tests of the effects of drug treatment on the estimates of daily rates of gametocytogenesis are summarized in Table III . Rates of gametocytogenesis increased as the infection progressed, with most conversion rates below the overall median early in the infection and most above the median toward the end (Figs. 7 and 8 ). This pattern differed quite markedly following chemotherapy: almost 50% of infections had rates of gametocytogenesis above the median immediately following drug treatment (on day 5 pi) and 80% had rates above the median (compared with 40% in untreated infections) on day 10 pi (Fig. 7) . In general, the different drugs generated similar patterns of gametocytogenesis through time, except on day 5 pi when, unlike quinine- and pyrimethamine-treated infections, no mefloquinetreated infections had high rates of gametocytogenesis (Fig.  7) . Prophylaxis had little effect on patterns of gametocytogenesis through time. The only exception was on day 10 pi, when conversion rates above median were substantially more frequent than in untreated infections (60 and 20%, respectively; Fig. 8 importance during the first 2 days following drug administra-DISCUSSION tion, a period excluded from our calculation of total numbers of parasites (assuming a maximum half-life of 18 h, after 36 h maximum drug concentration, ϭ original concentration All drugs, whether used as therapy or prophylaxis, reduced ϫ 0.5 2 ). It also seems highly unlikely that other sources of the number of asexual parasites produced during infections.
differential mortality may affect our interpretations. DifferHowever, gametocyte densities were not markedly reduced ences in stage-specific immune mortality due to drug treatfollowing pyrimethamine and mefloquine therapy or prophyment would require the existence of an as yet unknown laxis with either chloroquine or pyrimethamine. Quinine therapy did result in a small decrease in total gametocytes (approximately 25%, relative to untreated infections) but that was less than the associated reductions in asexual parasites. These data support the view that, during the course of an infection, a given number of asexual parasites produce more gametocytes following drug treatment.
An alternative possibility, that our observations are due to increased mortality of asexuals relative to gametocytes, can be ruled out. The antimalarial drugs that we used are known to be more damaging to asexual parasites than to mature gametocytes (Desjardins et al. 1988) . However, the effective half-life of mefloquine in mice is estimated to be 18 h (Desjardins et al. 1988 ) and while detailed pharmacokinetic data from mice are not available for the other drugs, extrapolation from human data suggests that this will be the longest half-life of the drugs used (Peters 1987) . For all drugs, preliminary studies showed that concentrations 25% of those actually used had no effect on asexual growth. uals through drug use is therefore only of any potential gametocyte-specific clearance mechanism (Taylor and Read (Carter and Graves 1988) and, at least in vitro, P. falciparum gametocytogenesis is also more frequent when asexual 1997), which is suppressed by all the antimalarial drugs used.
In all infections, rates of gametocytogenesis remained low growth is inhibited in general (Carter and Miller 1979; Brockelman 1982; Carter and Graves 1988 ; Bruce et al. and then rapidly increased up to much higher values toward the end of the infection. Alterations in daily rates of gameto-1990; Sinden et al. 1996) , and specifically by antimalarial drugs (Buckling et al. 1999) . Our results may therefore have cytogenesis were more pronounced when drug treatment occured during rather than before infection, presumably beimplications for antimalarial drug use against P. falciparum in the field. First, reductions in transmission bought about cause therapy is more damaging to asexual parasites (as indicated by the greater reduction in total numbers of asexby subcurative antimalarial treatment may be much less than expected from reductions in asexual densities if average uals). Notably, there was an immediate elevation in gametocytogenesis following administration of pyrimethamine and rates of gametocytogenesis are simultaneously increased. Second, drug therapy may stimulate high rates of gametocyquinine to infected mice. Such a rapid response to stressful conditions is consistent with studies on P. falciparum in togenesis to occur earlier than in untreated infections, resulting in earlier high infectivity. Such a phenotype will vitro (Carter and Miller 1979; Brockelman 1982; Bruce et al. 1990) .
potentially increase transmission under conditions in which the speed of transmission is a major component in parasite This immediate increase was not, however, observed following mefloquine therapy. It is possible that malaria parafitness (e.g., during epidemics). Third, if drugs are used in doses that are lethal to drug-sensitive but not resistant sites do not respond to mefloquine-imposed stress. Alternatively, the effect occurred but was not detected because parasites, changes in gametocyte production in response to drug-imposed stress may help to explain the rapid spread gametocyte densities in mefloquine-treated infections were generally below the detection threshold on day 7 pi. Mefloof drug resistance (Peters 1987) . Drug treatment may further enhance transmission as a result of reduced host immunity quine is much faster acting than quinine and especially pyrimethamine (Desjardins et al. 1988) , so that fewer parasites through decreased exposure to the parasite (Graves et al. 1988) , increases in per gametocyte infectivity (Butcher will have survived on day 5 pi to produce the gametocytes observed on day 7 pi. Chemotherapy with chloroquine, a 1997), and genetic changes in patterns of gametocytogenesis (Bishop 1954; Lines et al. 1991; Handunnetti et al. 1996) . similarly fast-acting drug, generates almost identical gametocyte dynamics (Buckling et al. 1997) . More generally, Partially effective vaccines may also stress parasites, at least in the short term. If so, they too may generate compendaily rates of gametocytogenesis calculated over 2-day periods will have been underestimated if mortality of asexual satory gametocyte production similar to that observed in this study. In vitro, P. falciparum gametocyte production parasites is greater during the first 24 h than the second. This was likely the case immediately following treatment increased following the addition of serum and lymphocytes from P. falciparum-infected children (Smalley and Brown with all the antimalarial drugs used.
P. chabaudi appears to increase gametocytogenesis when 1981) and anti-P. falciparum antibody (Ono et al. 1986 ). More generally, facultative changes in parasite life histories conditions are unfavorable for asexual replication. In addition to drug treatment, gametocytogenesis increased as the may render medical and veterinary intervention less effective than anticipated. infection progressed and the parasite numbers were suppressed by the host immune system (Fig. 9) . Similarly, parasites from longer established P. falciparum infections of ACKNOWLEDGMENTS Gambian children (as determined by the presence of mature gametocytes) had rates of gametocytogenesis six times
